Human papillomavirus oncogene mRNA testing for the detection of anal dysplasia in HIV-positive men who have sex with men

Journal of Clinical Virology

Volumn 53, Issue 4, 2012, Pages 325-331

  Silling, Steffi ^a   Kreuter, Alexander ^b   Hellmich, Martin ^c   Swoboda, Jochen ^d   Pfister, Herbert ^a   Wieland, Ulrike ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^d Institute of Cytology   (Germany)

Author keywords

Anal dysplasia; E6 E7 mRNA; Human immunodeficiency virus (HIV); Human papillomavirus (HPV); Men who have sex with men (MSM)

Indexed keywords

DNA; MESSENGER RNA;

ANAL DYSPLASIA; ANUS DISEASE; ARTICLE; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 45; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MICROBIOLOGICAL EXAMINATION; NEOPLASM; ONCOGENE; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; WART VIRUS;

ANAL CANAL; ANUS NEOPLASMS; DNA, VIRAL; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; PREVALENCE; REAGENT KITS, DIAGNOSTIC; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY;

EID: 84858151088     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.12.029     Document Type: Article

References (59)

1. Bernard H.U., Burk R.D., Chen Z., van Doorslaer K., Hausen H., de Villiers E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401:70-79.
2. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009, 10:321-322.
3. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527.
4. Einstein M.H., Schiller J.T., Viscidi R.P., Strickler H.D., Coursaget P., Tan T., et al. Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis 2009, 9:347-356.
5. Schiffman M., Castle P.E., Jeronimo J., Rodriguez A.C., Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007, 370:890-907.
6. Kreuter A., Wieland U. Human papillomavirus-associated diseases in HIV-infected men who have sex with men. Curr Opin Infect Dis 2009, 22:109-114.
7. Palefsky J.M. Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol 2009, 21:433-438.
8. Palefsky J.M., Holly E.A., Efirdc J.T., Da Costa M., Jay N., Berry J.M., et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005, 19:1407-1414.
9. Kreuter A., Potthoff A., Brockmeyer N.H., Gambichler T., Swoboda J., Stucker M., et al. Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol 2010, 162:1269-1277.
10. Salit I.E., Lytwyn A., Raboud J., Sano M., Chong S., Diong C., et al. The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS 2010, 24:1307-1313.
11. Weis S.E., Vecino I., Pogoda J.M., Susa J.S., Nevoit J., Radaford D., et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011, 54:433-441.
12. de Pokomandy A., Rouleau D., Ghattas G., Trottier H., Vezina S., Cote P., et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011, 52:1174-1181.
13. Shiels M.S., Pfeiffer R.M., Gail M.H., Hall H.I., Li J., Chaturvedi A.K., et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst 2011, 103:753-762.
14. Darragh T.M., Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol 2011, 119:5-19.
15. Lacey H.B., Wilson G.E., Tilston P., Wilkins E.G., Bailey A.S., Corbitt G., et al. A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 1999, 75:172-177.
16. Palefsky J.M., Holly E.A., Ralston M.L., Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998, 177:361-367.
17. Salit I.E., Tinmouth J., Chong S., Raboud J., Diong C., Su D., et al. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev 2009, 18:1986-1992.
18. Benevolo M., Vocaturo A., Caraceni D., French D., Rosini S., Zappacosta R., et al. Sensitivity, specificity, and clinical value of human papillomavirus (HPV) E6/E7 mRNA assay as a triage test for cervical cytology and HPV DNA test. J Clin Microbiol 2011, 49:2643-2650.
19. Burger E.A., Kornor H., Klemp M., Lauvrak V., Kristiansen I.S. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: a systematic review. Gynecol Oncol 2011, 120:430-438.
20. Cattani P., Zannoni G.F., Ricci C., D'Onghia S., Trivellizzi I.N., Di Franco A., et al. Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. J Clin Microbiol 2009, 47:3895-3901.
21. Halfon P., Benmoura D., Agostini A., Khiri H., Martineau A., Penaranda G., et al. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay. J Clin Virol 2010, 47:177-181.
22. Hovland S., Arbyn M., Lie A.K., Ryd W., Borge B., Berle E.J., et al. A comprehensive evaluation of the accuracy of cervical pre-cancer detection methods in a high-risk area in East Congo. Br J Cancer 2010, 102:957-965.
23. Keegan H., Mc Inerney J., Pilkington L., Gronn P., Silva I., Karlsen F., et al. Comparison of HPV detection technologies: hybrid capture 2, PreTect HPV-Proofer and analysis of HPV DNA viral load in HPV16, HPV18 and HPV33 E6/E7 mRNA positive specimens. J Virol Methods 2009, 155:61-66.
24. Molden T., Kraus I., Karlsen F., Skomedal H., Nygard J.F., Hagmar B. Comparison of human papillomavirus messenger RNA and DNA detection: a cross-sectional study of 4,136 women >30 years of age with a 2-year follow-up of high-grade squamous intraepithelial lesion. Cancer Epidemiol Biomarkers Prev 2005, 14:367-372.
25. Ratnam S., Coutlee F., Fontaine D., Bentley J., Escott N., Ghatage P., et al. Clinical performance of the PreTect HPV-Proofer E6/E7 mRNA assay in comparison with that of the Hybrid Capture 2 test for identification of women at risk of cervical cancer. J Clin Microbiol 2010, 48:2779-2785.
26. Reuschenbach M., Clad A., von Knebel Doeberitz C., Wentzensen N., Rahmsdorf J., Schaffrath F., et al. Performance of p16INK4a-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia in women with abnormal screening results. Gynecol Oncol 2010, 119:98-105.
27. Szarewski A., Ambroisine L., Cadman L., Austin J., Ho L., Terry G., et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 2008, 17:3033-3042.
28. Trope A., Sjoborg K., Eskild A., Cuschieri K., Eriksen T., Thoresen S., et al. Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia. J Clin Microbiol 2009, 47:2458-2464.
29. Berry J.M., Palefsky J.M., Welton M.L. Anal cancer and its precursors in HIV-positive patients: perspectives and management. Surg Oncol Clin N Am 2004, 13:355-373.
30. Wright T.C., Cox J.T., Massad L.S., Twiggs L.B., Wilkinson E.J. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002, 287:2120-2129.
31. Fenger C., Nielsen V.T. Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand A 1981, 89:463-465.
32. Schmitt M., Bravo I.G., Snijders P.J., Gissmann L., Pawlita M., Waterboer T. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006, 44:504-512.
33. Wieland U., Ritzkowsky A., Stoltidis M., Weissenborn S., Stark S., Ploner M., et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association?. J Invest Dermatol 2000, 115:124-128.
34. Weissenborn S.J., Funke A.M., Hellmich M., Mallmann P., Fuchs P.G., Pfister H.J., et al. Oncogenic human papillomavirus DNA loads in human immunodeficiency virus-positive women with high-grade cervical lesions are strongly elevated. J Clin Microbiol 2003, 41:2763-2767.
35. Weissenborn S.J., Wieland U., Junk M., Pfister H. Quantification of beta-human papillomavirus DNA by real-time PCR. Nat Protoc 2010, 5:1-13.
36. Molden T., Kraus I., Skomedal H., Nordstrom T., Karlsen F. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses. J Virol Methods 2007, 142:204-212.
37. Wilson E.B. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927, 22:209-212.
38. Boulet G.A., Micalessi I.M., Horvath C.A., Benoy I.H., Depuydt C.E., Bogers J.J. Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification. J Clin Microbiol 2010, 48:2524-2529.
39. Getman D., Aiyer A., Dockter J., Giachetti C., Zhang F., Ginocchio C.C. Efficiency of the APTIMA HPV assay for detection of HPV RNA and DNA targets. J Clin Virol 2009, 45(Suppl. 1):S49-S54.
40. Munger K., Phelps W.C., Bubb V., Howley P.M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 1989, 63:4417-4421.
41. zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384:260-265.
42. Castle P.E., Dockter J., Giachetti C., Garcia F.A., McCormick M.K., Mitchell A.L., et al. A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res 2007, 13:2599-2605.
43. Clad A., Reuschenbach M., Weinschenk J., Grote R., Rahmsdorf J., Freudenberg N. Performance of the Aptima high-risk human papillomavirus mRNA assay in a referral population in comparison with Hybrid Capture 2 and cytology. J Clin Microbiol 2011, 49:1071-1076.
44. Coquillard G., Palao B., Patterson B.K. Quantification of intracellular HPV E6/E7 mRNA expression increases the specificity and positive predictive value of cervical cancer screening compared to HPV DNA. Gynecol Oncol 2011, 120:89-93.
45. Cuschieri K., Wentzensen N. Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2008, 17:2536-2545.
46. Dockter J., Schroder A., Hill C., Guzenski L., Monsonego J., Giachetti C. Clinical performance of the APTIMA HPV assay for the detection of high-risk HPV and high-grade cervical lesions. J Clin Virol 2009, 45(Suppl. 1):S55-S61.
47. Ratnam S., Coutlee F., Fontaine D., Bentley J., Escott N., Ghatage P., et al. Aptima HPV E6/E7 mRNA test is as sensitive as Hybrid Capture 2 Assay but more specific at detecting cervical precancer and cancer. J Clin Microbiol 2011, 49:557-564.
48. Narimatsu R., Patterson B.K. High-throughput cervical cancer screening using intracellular human papillomavirus E6 and E7 mRNA quantification by flow cytometry. Am J Clin Pathol 2005, 123:716-723.
49. Valari O., Koliopoulos G., Karakitsos P., Valasoulis G., Founta C., Godevenos D., et al. Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: Predictors and clinical implications. Gynecol Oncol 2011, S0090-8258(11)00430-6.
50. Andersson S., Hansson B., Norman I., Gaberi V., Mints M., Hjerpe A., et al. Expression of E6/E7 mRNA from 'high risk' human papillomavirus in relation to CIN grade, viral load and p16INK4a. Int J Oncol 2006, 29:705-711.
51. Abramowitz L., Jacquard A.C., Jaroud F., Haesebaert J., Siproudhis L., Pradat P., et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 2011, 129:433-439.
52. De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124:1626-1636.
53. Hoots B.E., Palefsky J.M., Pimenta J.M., Smith J.S. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009, 124:2375-2383.
54. Wong A.K., Chan R.C., Aggarwal N., Singh M.K., Nichols W.S., Bose S. Human papillomavirus genotypes in anal intraepithelial neoplasia and anal carcinoma as detected in tissue biopsies. Mod Pathol 2010, 23:144-150.
55. Andersson E., Karrberg C., Radberg T., Blomqvist L., Zetterqvist B.M., Ryd W., et al. Type-specific human papillomavirus E6/E7 mRNA detection by real-time PCR improves identification of cervical neoplasia. J Clin Microbiol 2011, 49:3794-3799.
56. Sorbye S.W., Fismen S., Gutteberg T., Mortensen E.S. Triage of women with minor cervical lesions: data suggesting a "test and treat" approach for HPV E6/E7 mRNA testing. PLoS One 2010, 5:e12724.
57. Ho C.M., Lee B.H., Chang S.F., Chien T.Y., Huang S.H., Yan C.C., et al. Type-specific human papillomavirus oncogene messenger RNA levels correlate with the severity of cervical neoplasia. Int J Cancer 2010, 127:622-632.
58. Schmitt M., Dalstein V., Waterboer T., Clavel C., Gissmann L., Pawlita M. Diagnosing cervical cancer and high-grade precursors by HPV16 transcription patterns. Cancer Res 2010, 70:249-256.
59. Schmitt M., Dalstein V., Waterboer T., Clavel C., Gissmann L., Pawlita M. The HPV16 transcriptome in cervical lesions of different grades. Mol Cell Probes 2011, S0890-8508(11)00033-8.